HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1401	19909 Clark PA, Treisman DM, Ebben J, Kuo JS Developmental signaling pathways in brain tumor-derived stem-like cells DEVELOPMENTAL DYNAMICS. 2007 DEC; 236 (12): 3297-3308	0	23	13	168
1402	20485 Kumar-Singh S Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques GENES BRAIN AND BEHAVIOR. 2008 FEB; 7: 67-82	3	17	29	168
1403	21755 Kobeissy FH, Sadasivan S, Oli MW, Robinson G, Larner SF, et al. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation PROTEOMICS CLINICAL APPLICATIONS. 2008 OCT; 2 (10-11): 1467-1483	0	1	22	168
1404	21832 Oken BS Placebo effects: clinical aspects and neurobiology BRAIN. 2008 NOV; 131: 2812-2823	0	18	4	168
1405	22527 Jeibmann A, Paulus W Drosophila melanogaster as a Model Organism of Brain Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 FEB; 10 (2): 407-440	2	5	45	168
1406	23926 Mohajeri MH, Leuba G Prevention of age-associated dementia BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 315-325	1	3	29	168
1407	24687 Strong MJ The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 JAN 15; 288 (1-2): 1-12	10	12	53	168
1408	25308 Fevre-Montange M, Vasiljevic A, Champier J, Jouvet A Histopathology of tumors of the pineal region FUTURE ONCOLOGY. 2010 MAY; 6 (5): 791-809	1	1	19	168
1409	26124 Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, et al. Mouse behavioral endophenotypes for schizophrenia BRAIN RESEARCH BULLETIN. 2010 SEP 30; 83 (3-4): 147-161	0	0	7	168
1410	4995 Dickson DW The pathogenesis of senile plaques JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1997 APR; 56 (4): 321-339	136	360	37	167
#	Date / Author / Journal	LCS	GCS	LCR	CR
1411	5982 Small DH The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration? NEUROCHEMICAL RESEARCH. 1998 MAY; 23 (5): 795-806	10	24	13	167
1412	7863 Rao MS, Mayer-Proschel M Precursor cells for transplantation NEURAL PLASTICITY AND REGENERATION. 2000; 128: 273-292	3	22	12	167
1413	8509 Emmerling MR, Watson MD, Raby CA, Spiegel K The role of complement in Alzheimer's disease pathology BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2000 JUL 26; 1502 (1): 158-171	6	43	6	167
1414	10199 Jellinger KA Recent developments in the pathology of Parkinson's disease AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS. 2002; : 347-376	0	0	48	167
1415	11650 Jenner P Oxidative stress in Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S26-S36	92	349	7	167
1416	12434 Lu DY, Mahmood A, Chopp M Biologic transplantation and neurotrophin-induced neuroplasticity after traumatic brain injury JOURNAL OF HEAD TRAUMA REHABILITATION. 2003 JUL-AUG; 18 (4): 357-376	2	20	15	167
1417	13265 Schwartzkroin PA, Roper SN, Wenzel HJ Cortical dysplasia and epilepsy: Animal models RECENT ADVANCES IN EPILEPSY RESEARCH. 2004; 548: 145-174	0	14	12	167
1418	16380 Liu B Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease AAPS JOURNAL. 2006; 8 (3): E606-E621	2	25	10	167
1419	18166 Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, et al. Recent advances in the development of amyloid Imaging agents CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007; 7 (18): 1773-1789	5	15	81	167
1420	18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147	6	30	37	167
#	Date / Author / Journal	LCS	GCS	LCR	CR
1421	18445 Lalonde R, Strazielle C Brain regions and genes affecting postural control PROGRESS IN NEUROBIOLOGY. 2007 JAN; 81 (1): 45-60	0	17	16	167
1422	19420 Vawda R, Woodbury J, Covey M, Levison SW, Mehmet H Stem cell therapies for perinatal brain injuries SEMINARS IN FETAL & NEONATAL MEDICINE. 2007 AUG; 12 (4): 259-272	0	4	13	167
1423	19785 Bazan NG Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid - The proctor lecture INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2007 NOV; 48 (11): 4866-4881	0	30	4	167
1424	19901 Shkundina IS, Ter-Avanesyan MD Prions BIOCHEMISTRY-MOSCOW. 2007 DEC; 72 (13): 1519-1536	1	5	7	167
1425	20470 Philpott KL, Facci L MAP Kinase Pathways in Neuronal Cell Death CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 FEB; 7 (1): 83-97	1	10	13	167
1426	21836 Donnelly A, Blagg BSJ Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket CURRENT MEDICINAL CHEMISTRY. 2008 NOV; 15 (26): 2702-2717	3	37	11	167
1427	23167 Jayadev S, Garden GA Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 JUN; 4 (2): 175-189	0	1	7	167
1428	24753 Laskowska E, Matuszewska E, Kuczynska-Wisnik D Small Heat Shock Proteins and Protein-Misfolding Diseases CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 146-157	1	2	15	167
1429	24940 Carson J, Haddad D, Bressman M, Fong Y ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN DRUGS OF THE FUTURE. 2010 MAR; 35 (3): 183-195	0	0	15	167
1430	25220 Crews L, Masliah E Molecular mechanisms of neurodegeneration in Alzheimer's disease HUMAN MOLECULAR GENETICS. 2010 APR 15; 19: R12-R20	0	2	36	167
#	Date / Author / Journal	LCS	GCS	LCR	CR
1431	26710 Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 21-37	0	1	33	167
1432	1072 HINOVAPALOVA DV, PALOFF AM, USUNOFF KG, DIMOVA RN, YOSSIFOV TY, et al. RECIPROCAL CONNECTIONS BETWEEN THE CLAUSTRUM AND THE AUDITORY CORTICAL FIELDS IN THE CAT - AN EXPERIMENTAL-STUDY USING LIGHT AND ELECTRON- MICROSCOPIC ANTEROGRADE DEGENERATION METHODS, AND THE HORSERADISH- PEROXIDASE RETROGRADE AXONAL-TRANSPORT JOURNAL FUR HIRNFORSCHUNG. 1988; 29 (3): 255-278	1	11	17	166
1433	3859 SNIPES GJ, SUTER U MOLECULAR-BASIS OF COMMON HEREDITARY MOTOR AND SENSORY NEUROPATHIES IN HUMANS AND IN MOUSE MODELS BRAIN PATHOLOGY. 1995 JUL; 5 (3): 233-247	1	44	3	166
1434	4028 EISENBERG L THE SOCIAL CONSTRUCTION OF THE HUMAN BRAIN AMERICAN JOURNAL OF PSYCHIATRY. 1995 NOV; 152 (11): 1563-1575	1	123	2	166
1435	4245 Whittemore SR, Snyder EY Physiological relevance and functional potential of central nervous system-derived cell lines MOLECULAR NEUROBIOLOGY. 1996 FEB; 12 (1): 13-38	20	88	14	166
1436	4928 Shi SR, Cote RJ, Taylor CR Antigen retrieval immunohistochemistry: Past, present, and future JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 1997 MAR; 45 (3): 327-343	8	301	10	166
1437	4937 Bachus SE, Hyde TM, Herman MM, Egan MF, Kleinman JE Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics JOURNAL OF PSYCHIATRIC RESEARCH. 1997 MAR-APR; 31 (2): 233-256	6	37	7	166
1438	5006 Weber T, Zerr I, Bodemer M, Poser S Expanded disease spectrum of human spongiform encephalopathies or prion diseases NERVENARZT. 1997 APR; 68 (4): 309-323	4	6	1	166
1439	5301 Masliah E Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease LABORATORY INVESTIGATION. 1997 SEP; 77 (3): 197-209	6	12	19	166
1440	5889 Rovigatti U, Afanasyeva T, Brandner S, Hainfellner JA, Kiess M, et al. Transgenic mice as research tools in neurocarcinogenesis JOURNAL OF NEUROVIROLOGY. 1998 APR; 4 (2): 159-174	2	4	10	166
#	Date / Author / Journal	LCS	GCS	LCR	CR
1441	6273 Jenner P, Olanow CW Understanding cell death in Parkinson's disease ANNALS OF NEUROLOGY. 1998 SEP; 44 (3): S72-S84	33	184	3	166
1442	10287 Church SM, Cotter D, Bramon E, Murray RM Does schizophrenia result from developmental or degenerative processes? JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (63): 129-147	1	16	26	166
1443	12460 Frank R, Hargreaves R Clinical biomarkers in drug discovery and development NATURE REVIEWS DRUG DISCOVERY. 2003 JUL; 2 (7): 566-580	12	213	4	166
1444	15277 Meethal SV, Smith MA, Bowen RL, Atwood CS The gonadotropin connection in Alzheimer's disease ENDOCRINE. 2005 APR; 26 (3): 317-325	3	27	14	166
1445	15838 Raedt R, Boon P Cell therapy for neurological disorders: A comprehensive review ACTA NEUROLOGICA BELGICA. 2005 SEP; 105 (3): 158-170	0	7	27	166
1446	16427 Lastres-Becker I, Fernandez-Ruiz J An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments CURRENT MEDICINAL CHEMISTRY. 2006; 13 (30): 3705-3718	1	11	24	166
1447	16603 Lee YW, Hirani AA Role of interleukin-4 in atherosclerosis ARCHIVES OF PHARMACAL RESEARCH. 2006 JAN; 29 (1): 1-15	0	8	3	166
1448	18156 Montuschi P, Barnes P, Roberts LJ Insights into oxidative stress: The isoprostanes CURRENT MEDICINAL CHEMISTRY. 2007; 14 (6): 703-717	3	55	22	166
1449	18336 Kolomeets NS The pathology of the hippocampus in schizophrenia ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. 2007; 107 (12): 103-114	0	0	34	166
1450	20334 Iqbal K, Grundke-Iqbal I Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 JAN-FEB; 12 (1): 38-55	13	27	90	166
#	Date / Author / Journal	LCS	GCS	LCR	CR
1451	21569 Cetas JS, Saedi T, Burchiel KJ Destructive procedures for the treatment of nonmalignant pain: a structured literature review JOURNAL OF NEUROSURGERY. 2008 SEP; 109 (3): 389-404	0	5	2	166
1452	22415 Vitale A, Manciocco A, Alleva E The 3R principle and the use of non-human primates in the study of neurodegenerative diseases: The case of Parkinson's disease NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 JAN; 33 (1): 33-47	0	5	12	166
1453	23276 Waxman EA, Giasson BI Molecular mechanisms of alpha-synuclein neurodegeneration BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 616-624	23	30	141	166
1454	23631 Sloan LA, Fillmore MC, Churcher I Small-molecule modulation of cellular chaperones to treat protein misfolding disorders CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2009 SEP; 12 (5): 666-681	0	3	11	166
1455	24936 Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, et al. Novel therapeutics for Alzheimer's disease: An update CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 MAR; 13 (2): 235-246	1	5	40	166
1456	699 ACHTSTATTER T, MOLL R, ANDERSON A, KUHN C, PITZ S, et al. EXPRESSION OF GLIAL FILAMENT PROTEIN (GFP) IN NERVE SHEATHS AND NONNEURAL CELLS REEXAMINED USING MONOCLONAL-ANTIBODIES, WITH SPECIAL EMPHASIS ON THE COEXPRESSION OF GFP AND CYTOKERATINS IN EPITHELIAL- CELLS OF HUMAN SALIVARY-GLAND AND PLEOMORPHIC ADENOMAS DIFFERENTIATION. 1986; 31 (3): 206-227	19	98	4	165
1457	1762 FREED WJ, POLTORAK M, BECKER JB INTRACEREBRAL ADRENAL-MEDULLA GRAFTS - A REVIEW EXPERIMENTAL NEUROLOGY. 1990 NOV; 110 (2): 139-166	28	127	6	165
1458	6043 Marani E Microwave applications in neuromorphology and neurochemistry: Safety precautions and techniques METHODS. 1998 JUN; 15 (2): 87-99	0	8	4	165
1459	6831 Gundersen GG, Cook TA Microtubules and signal transduction CURRENT OPINION IN CELL BIOLOGY. 1999 FEB; 11 (1): 81-94	11	244	17	165
1460	8964 Priola SA Prion protein diversity and disease in the transmissible spongiform encephalopathies ADVANCES IN PROTEIN CHEMISTRY, VOL 57. 2001; 57: 1-27	0	13	9	165
#	Date / Author / Journal	LCS	GCS	LCR	CR
1461	8966 Aguzzi A, Brandner S, Fischer MB, Furukawa H, Glatzel M, et al. Spongiform encephalopathies: Insights from transgenic models ADVANCES IN VIRUS RESEARCH, VOL 56. 2001; 56: 313-352	3	10	10	165
1462	9119 Selemon LD Regionally diverse cortical pathology in schizophrenia: Clues to the etiology of the disease SCHIZOPHRENIA BULLETIN. 2001; 27 (3): 349-377	7	52	25	165
1463	11439 Miksys SL, Tyndale RF Drug-metabolizing cytochrome P450s in the brain JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2002 NOV; 27 (6): 406-415	2	54	3	165
1464	12071 Shiraishi T, Tabuchi K Genetic alterations of human brain tumors as molecular prognostic factors NEUROPATHOLOGY. 2003 MAR; 23 (1): 95-108	0	6	5	165
1465	12461 Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, et al. Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease NEUROBIOLOGY OF AGING. 2003 JUL-AUG; 24 (4): 521-536	120	119	32	165
1466	13194 Levy YS, Stroomza M, Melamed E, Offen D Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 353-385	10	21	31	165
1467	16346 Boyd AS, Higashi Y, Wood KJ Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation ADVANCED DRUG DELIVERY REVIEWS. 2005 DEC 12; 57 (13): 1944-1969	0	23	3	165
1468	16537 Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, et al. Deep brain stimulation: Postoperative issues MOVEMENT DISORDERS. 2006; 21: S219-S237	8	53	4	165
1469	17849 Croisier E, Graeber MB Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 517-530	15	37	55	165
1470	17944 Burns A, O'Brien J Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology JOURNAL OF PSYCHOPHARMACOLOGY. 2006 NOV; 20 (6): 732-755	10	54	6	165
#	Date / Author / Journal	LCS	GCS	LCR	CR
1471	18199 de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease IMAGING AND THE AGING BRAIN. 2007; 1097: 114-145	22	55	46	165
1472	18944 Houben F, Ramaekers FCS, Snoeckx LHEH, Broers JLV Role of nuclear lamina-cytoskeleton interactions in the maintenance of cellular strength BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2007 MAY; 1773 (5): 675-686	0	24	1	165
1473	20046 Uversky VN, Oldfield CJ, Dunker AK Intrinsically disordered proteins in human diseases: Introducing the D- 2 concept ANNUAL REVIEW OF BIOPHYSICS. 2008; 37: 215-246	15	96	18	165
1474	21730 Rebolledo DL, Minniti AN, Grez PM, Fadic R, Kohn R, et al. Inclusion Body Myositis: A View from the Caenorhabditis elegans Muscle MOLECULAR NEUROBIOLOGY. 2008 OCT; 38 (2): 178-196	1	4	20	165
1475	23905 Lucin KM, Wyss-Coray T Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little? NEURON. 2009 OCT 15; 64 (1): 110-122	9	35	18	165
1476	24025 Farin A, Liu CY, Langmoen IA, Apuzzo MLJ BIOLOGICAL RESTORATION OF CENTRAL NERVOUS SYSTEM ARCHITECTURE AND FUNCTION: PART 3-STEM CELL- AND CELL-BASED APPLICATIONS AND REALITIES IN THE BIOLOGICAL MANAGEMENT OF CENTRAL NERVOUS SYSTEM DISORDERS: TRAUMATIC, VASCULAR, AND EPILEPSY DISORDERS NEUROSURGERY. 2009 NOV; 65 (5): 831-859	0	0	38	165
1477	25191 Chouliaras L, Rutten BPF, Kenis G, Peerbooms O, Visser PJ, et al. Epigenetic regulation in the pathophysiology of Alzheimer's disease PROGRESS IN NEUROBIOLOGY. 2010 APR; 90 (4): 498-510	1	8	17	165
1478	25387 Frade JM, Lopez-Sanchez N A novel hypothesis for Alzheimer's disease based on neuronal tetraploidy induced by p75(NTR) CELL CYCLE. 2010 MAY 15; 9 (10): 1934-1941	0	0	35	165
1479	25457 Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, et al. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 334-346	3	3	43	165
1480	26073 Kadir A, Nordberg A Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia JOURNAL OF NUCLEAR MEDICINE. 2010 SEP 1; 51 (9): 1418-1430	0	0	54	165
#	Date / Author / Journal	LCS	GCS	LCR	CR
1481	605 JAYARAMAN A ORGANIZATION OF THALAMIC PROJECTIONS IN THE NUCLEUS ACCUMBENS AND THE CAUDATE-NUCLEUS IN CATS AND ITS RELATION WITH HIPPOCAMPAL AND OTHER SUBCORTICAL AFFERENTS JOURNAL OF COMPARATIVE NEUROLOGY. 1985; 231 (3): 396-420	0	83	8	164
1482	886 SCHEITHAUER BW, BRUNER JM THE ULTRASTRUCTURAL SPECTRUM OF ASTROCYTIC NEOPLASMS ULTRASTRUCTURAL PATHOLOGY. 1987; 11 (5-6): 535-581	3	21	4	164
1483	1823 GREENBERG BD, KEZDY FJ, KISILEVSKY R AMYLOIDOGENESIS AS A THERAPEUTIC TARGET IN ALZHEIMERS-DISEASE ANNUAL REPORTS IN MEDICINAL CHEMISTRY. 1991; 26: 229-238	11	16	4	164
1484	3882 PANTONI L, GARCIA JH THE SIGNIFICANCE OF CEREBRAL WHITE-MATTER ABNORMALITIES 100 YEARS AFTER BINSWANGERS REPORT - A REVIEW STROKE. 1995 JUL; 26 (7): 1293-1301	24	314	30	164
1485	6504 Rogers MA, Bradshaw JL, Pantelis C, Phillips JG Frontostriatal deficits in unipolar major depression BRAIN RESEARCH BULLETIN. 1998 NOV 1; 47 (4): 297-310	1	86	4	164
1486	7884 Dryhurst G, Shen XM, Li H, Yang ZL, Han JL, et al. Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 181-209	0	1	4	164
1487	7895 Schallert T, Bland ST, Fleming SM Functional recovery after brain injury: role of neurotrophic factors and behavior-driven structural events PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 329-344	1	5	4	164
1488	9238 Bigler ED The lesion(s) in traumatic brain injury: implications for clinical neuropsychology ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2001 FEB; 16 (2): 95-131	3	54	9	164
1489	9406 Lam PYP, Breakefield XO Potential of gene therapy for brain tumors HUMAN MOLECULAR GENETICS. 2001 APR; 10 (7): 777-787	2	41	7	164
1490	11274 Thompson AJ, Barrow CJ Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and prion diseases CURRENT MEDICINAL CHEMISTRY. 2002 OCT; 9 (19): 1751-1762	7	23	32	164
#	Date / Author / Journal	LCS	GCS	LCR	CR
1491	12843 Ciechanover A, Brundin P The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg NEURON. 2003 OCT 9; 40 (2): 427-446	101	319	60	164
1492	13130 Brown DR, Kozlowski H Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases DALTON TRANSACTIONS. 2004; (13): 1907-1917	9	86	11	164
1493	13153 Ben-Shachar D, Laifenfeld D Mitochondria, synaptic plasticity, and schizophrenia DISORDERS OF SYNAPTIC PLASTICITY AND SCHIZOPHRENIA. 2004; 59: 273-296	4	53	17	164
1494	14614 Bulte JWM, Kraitchman DL Monitoring cell therapy using iron oxide MR contrast agents CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2004 DEC; 5 (6): 567-584	1	61	8	164
1495	15516 Sun Y, MacRae TH The small heat shock proteins and their role in human disease FEBS JOURNAL. 2005 JUN; 272 (11): 2613-2627	10	129	14	164
1496	16383 Maruszak A, Gaweda-Walerych K, Soltyszewski I, Kekanowski C Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases ACTA NEUROBIOLOGIAE EXPERIMENTALIS. 2006; 66 (2): 153-176	1	4	27	164
1497	16782 Shults CW Lewy bodies PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 FEB 7; 103 (6): 1661-1668	69	108	110	164
1498	16994 Bacman SR, Bradley WG, Moraes CT Mitochondrial involvement in amyotrophic lateral sclerosis - Trigger or target? MOLECULAR NEUROBIOLOGY. 2006 APR; 33 (2): 113-131	7	18	23	164
1499	17798 Hardy J A hundred years of Alzheimer's disease research NEURON. 2006 OCT 5; 52 (1): 3-13	29	93	24	164
1500	18567 D Roses A, Saunders AM, Huang Y, Strum J, Weisgraber KH, et al. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease) PHARMACOGENOMICS JOURNAL. 2007 FEB; 7 (1): 10-28	0	1	20	164

Date / Author / Journal

LCS

GCS

LCR

1401

19909 Clark PA, Treisman DM, Ebben J, Kuo JS

Developmental signaling pathways in brain tumor-derived stem-like cells

DEVELOPMENTAL DYNAMICS. 2007 DEC; 236 (12): 3297-3308

168

1402

20485 Kumar-Singh S

Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques

GENES BRAIN AND BEHAVIOR. 2008 FEB; 7: 67-82

168

1403

21755 Kobeissy FH, Sadasivan S, Oli MW, Robinson G, Larner SF, et al.

Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation

PROTEOMICS CLINICAL APPLICATIONS. 2008 OCT; 2 (10-11): 1467-1483

168

1404

21832 Oken BS

Placebo effects: clinical aspects and neurobiology

BRAIN. 2008 NOV; 131: 2812-2823

168

1405

22527 Jeibmann A, Paulus W

Drosophila melanogaster as a Model Organism of Brain Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 FEB; 10 (2): 407-440

168

1406

23926 Mohajeri MH, Leuba G

Prevention of age-associated dementia

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 315-325

168

1407

24687 Strong MJ

The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 JAN 15; 288 (1-2): 1-12

168

1408

25308 Fevre-Montange M, Vasiljevic A, Champier J, Jouvet A

Histopathology of tumors of the pineal region

FUTURE ONCOLOGY. 2010 MAY; 6 (5): 791-809

168

1409

26124 Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, et al.

Mouse behavioral endophenotypes for schizophrenia

BRAIN RESEARCH BULLETIN. 2010 SEP 30; 83 (3-4): 147-161

168

1410

4995 Dickson DW

The pathogenesis of senile plaques

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 1997 APR; 56 (4): 321-339

136

360

167

Date / Author / Journal

1411

The role of the amyloid protein precursor (APP) in Alzheimer's disease: Does the normal function of APP explain the topography of neurodegeneration?

NEUROCHEMICAL RESEARCH. 1998 MAY; 23 (5): 795-806

167

1412

7863 Rao MS, Mayer-Proschel M

Precursor cells for transplantation

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 273-292

167

1413

8509 Emmerling MR, Watson MD, Raby CA, Spiegel K

The role of complement in Alzheimer's disease pathology

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2000 JUL 26; 1502 (1): 158-171

167

1414

10199 Jellinger KA

Recent developments in the pathology of Parkinson's disease

AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS. 2002; : 347-376

167

1415

11650 Jenner P

Oxidative stress in Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S26-S36

349

167

1416

12434 Lu DY, Mahmood A, Chopp M

Biologic transplantation and neurotrophin-induced neuroplasticity after traumatic brain injury

JOURNAL OF HEAD TRAUMA REHABILITATION. 2003 JUL-AUG; 18 (4): 357-376

167

1417

13265 Schwartzkroin PA, Roper SN, Wenzel HJ

Cortical dysplasia and epilepsy: Animal models

RECENT ADVANCES IN EPILEPSY RESEARCH. 2004; 548: 145-174

167

1418

16380 Liu B

Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease

AAPS JOURNAL. 2006; 8 (3): E606-E621

167

1419

18166 Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, et al.

Recent advances in the development of amyloid Imaging agents

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007; 7 (18): 1773-1789

167

1420

18285 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, et al.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2007; 31 (1): 125-147

167

Date / Author / Journal

LCS

GCS

LCR

1421

18445 Lalonde R, Strazielle C

Brain regions and genes affecting postural control

PROGRESS IN NEUROBIOLOGY. 2007 JAN; 81 (1): 45-60

167

1422

19420 Vawda R, Woodbury J, Covey M, Levison SW, Mehmet H

Stem cell therapies for perinatal brain injuries

SEMINARS IN FETAL & NEONATAL MEDICINE. 2007 AUG; 12 (4): 259-272

167

1423

19785 Bazan NG

Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid - The proctor lecture

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2007 NOV; 48 (11): 4866-4881

167

1424

19901 Shkundina IS, Ter-Avanesyan MD

Prions

BIOCHEMISTRY-MOSCOW. 2007 DEC; 72 (13): 1519-1536

167

1425

20470 Philpott KL, Facci L

MAP Kinase Pathways in Neuronal Cell Death

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2008 FEB; 7 (1): 83-97

167

1426

21836 Donnelly A, Blagg BSJ

Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket

CURRENT MEDICINAL CHEMISTRY. 2008 NOV; 15 (26): 2702-2717

167

1427

23167 Jayadev S, Garden GA

Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders

JOURNAL OF NEUROIMMUNE PHARMACOLOGY. 2009 JUN; 4 (2): 175-189

167

1428

24753 Laskowska E, Matuszewska E, Kuczynska-Wisnik D

Small Heat Shock Proteins and Protein-Misfolding Diseases

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 146-157

167

1429

24940 Carson J, Haddad D, Bressman M, Fong Y

ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN

DRUGS OF THE FUTURE. 2010 MAR; 35 (3): 183-195

167

1430

25220 Crews L, Masliah E

Molecular mechanisms of neurodegeneration in Alzheimer's disease

HUMAN MOLECULAR GENETICS. 2010 APR 15; 19: R12-R20

167

Date / Author / Journal

LCS

GCS

LCR

1431

26710 Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P

Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis

ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 21-37

167

1432

1072 HINOVAPALOVA DV, PALOFF AM, USUNOFF KG, DIMOVA RN, YOSSIFOV TY, et al.

RECIPROCAL CONNECTIONS BETWEEN THE CLAUSTRUM AND THE AUDITORY CORTICAL FIELDS IN THE CAT - AN EXPERIMENTAL-STUDY USING LIGHT AND ELECTRON- MICROSCOPIC ANTEROGRADE DEGENERATION METHODS, AND THE HORSERADISH- PEROXIDASE RETROGRADE AXONAL-TRANSPORT

JOURNAL FUR HIRNFORSCHUNG. 1988; 29 (3): 255-278

166

1433

3859 SNIPES GJ, SUTER U

MOLECULAR-BASIS OF COMMON HEREDITARY MOTOR AND SENSORY NEUROPATHIES IN HUMANS AND IN MOUSE MODELS

BRAIN PATHOLOGY. 1995 JUL; 5 (3): 233-247

166

1434

4028 EISENBERG L

THE SOCIAL CONSTRUCTION OF THE HUMAN BRAIN

AMERICAN JOURNAL OF PSYCHIATRY. 1995 NOV; 152 (11): 1563-1575

123

166

1435

4245 Whittemore SR, Snyder EY

Physiological relevance and functional potential of central nervous system-derived cell lines

MOLECULAR NEUROBIOLOGY. 1996 FEB; 12 (1): 13-38

166

1436

4928 Shi SR, Cote RJ, Taylor CR

Antigen retrieval immunohistochemistry: Past, present, and future

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 1997 MAR; 45 (3): 327-343

301

166

1437

4937 Bachus SE, Hyde TM, Herman MM, Egan MF, Kleinman JE

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics

JOURNAL OF PSYCHIATRIC RESEARCH. 1997 MAR-APR; 31 (2): 233-256

166

1438

5006 Weber T, Zerr I, Bodemer M, Poser S

Expanded disease spectrum of human spongiform encephalopathies or prion diseases

NERVENARZT. 1997 APR; 68 (4): 309-323

166

1439

5301 Masliah E

Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease

LABORATORY INVESTIGATION. 1997 SEP; 77 (3): 197-209

166

1440

5889 Rovigatti U, Afanasyeva T, Brandner S, Hainfellner JA, Kiess M, et al.

Transgenic mice as research tools in neurocarcinogenesis

JOURNAL OF NEUROVIROLOGY. 1998 APR; 4 (2): 159-174

166

Date / Author / Journal

LCS

GCS

LCR

1441

6273 Jenner P, Olanow CW

Understanding cell death in Parkinson's disease

ANNALS OF NEUROLOGY. 1998 SEP; 44 (3): S72-S84

184

166

1442

10287 Church SM, Cotter D, Bramon E, Murray RM

Does schizophrenia result from developmental or degenerative processes?

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (63): 129-147

166

1443

12460 Frank R, Hargreaves R

Clinical biomarkers in drug discovery and development

NATURE REVIEWS DRUG DISCOVERY. 2003 JUL; 2 (7): 566-580

213

166

1444

15277 Meethal SV, Smith MA, Bowen RL, Atwood CS

The gonadotropin connection in Alzheimer's disease

ENDOCRINE. 2005 APR; 26 (3): 317-325

166

1445

15838 Raedt R, Boon P

Cell therapy for neurological disorders: A comprehensive review

ACTA NEUROLOGICA BELGICA. 2005 SEP; 105 (3): 158-170

166

1446

16427 Lastres-Becker I, Fernandez-Ruiz J

An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments

CURRENT MEDICINAL CHEMISTRY. 2006; 13 (30): 3705-3718

166

1447

16603 Lee YW, Hirani AA

Role of interleukin-4 in atherosclerosis

ARCHIVES OF PHARMACAL RESEARCH. 2006 JAN; 29 (1): 1-15

166

1448

18156 Montuschi P, Barnes P, Roberts LJ

Insights into oxidative stress: The isoprostanes

CURRENT MEDICINAL CHEMISTRY. 2007; 14 (6): 703-717

166

1449

18336 Kolomeets NS

The pathology of the hippocampus in schizophrenia

ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA. 2007; 107 (12): 103-114

166

1450

20334 Iqbal K, Grundke-Iqbal I

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 JAN-FEB; 12 (1): 38-55

166

Date / Author / Journal

LCS

GCS

LCR

1451

21569 Cetas JS, Saedi T, Burchiel KJ

Destructive procedures for the treatment of nonmalignant pain: a structured literature review

JOURNAL OF NEUROSURGERY. 2008 SEP; 109 (3): 389-404

166

1452

22415 Vitale A, Manciocco A, Alleva E

The 3R principle and the use of non-human primates in the study of neurodegenerative diseases: The case of Parkinson's disease

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2009 JAN; 33 (1): 33-47

166

1453

23276 Waxman EA, Giasson BI

Molecular mechanisms of alpha-synuclein neurodegeneration

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2009 JUL; 1792 (7): 616-624

141

166

1454

23631 Sloan LA, Fillmore MC, Churcher I

Small-molecule modulation of cellular chaperones to treat protein misfolding disorders

CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2009 SEP; 12 (5): 666-681

166

1455

24936 Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, et al.

Novel therapeutics for Alzheimer's disease: An update

CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 MAR; 13 (2): 235-246

166

1456

699 ACHTSTATTER T, MOLL R, ANDERSON A, KUHN C, PITZ S, et al.

EXPRESSION OF GLIAL FILAMENT PROTEIN (GFP) IN NERVE SHEATHS AND NONNEURAL CELLS REEXAMINED USING MONOCLONAL-ANTIBODIES, WITH SPECIAL EMPHASIS ON THE COEXPRESSION OF GFP AND CYTOKERATINS IN EPITHELIAL- CELLS OF HUMAN SALIVARY-GLAND AND PLEOMORPHIC ADENOMAS

DIFFERENTIATION. 1986; 31 (3): 206-227

165

1457

1762 FREED WJ, POLTORAK M, BECKER JB

INTRACEREBRAL ADRENAL-MEDULLA GRAFTS - A REVIEW

EXPERIMENTAL NEUROLOGY. 1990 NOV; 110 (2): 139-166

127

165

1458

6043 Marani E

Microwave applications in neuromorphology and neurochemistry: Safety precautions and techniques

METHODS. 1998 JUN; 15 (2): 87-99

165

1459

6831 Gundersen GG, Cook TA

Microtubules and signal transduction

CURRENT OPINION IN CELL BIOLOGY. 1999 FEB; 11 (1): 81-94

244

165

1460

8964 Priola SA

Prion protein diversity and disease in the transmissible spongiform encephalopathies

ADVANCES IN PROTEIN CHEMISTRY, VOL 57. 2001; 57: 1-27

165

Date / Author / Journal

LCS

GCS

LCR

1461

8966 Aguzzi A, Brandner S, Fischer MB, Furukawa H, Glatzel M, et al.

Spongiform encephalopathies: Insights from transgenic models

ADVANCES IN VIRUS RESEARCH, VOL 56. 2001; 56: 313-352

165

1462

9119 Selemon LD

Regionally diverse cortical pathology in schizophrenia: Clues to the etiology of the disease

SCHIZOPHRENIA BULLETIN. 2001; 27 (3): 349-377

165

1463

11439 Miksys SL, Tyndale RF

Drug-metabolizing cytochrome P450s in the brain

JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2002 NOV; 27 (6): 406-415

165

1464

12071 Shiraishi T, Tabuchi K

Genetic alterations of human brain tumors as molecular prognostic factors

NEUROPATHOLOGY. 2003 MAR; 23 (1): 95-108

165

1465

12461 Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, et al.

Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

NEUROBIOLOGY OF AGING. 2003 JUL-AUG; 24 (4): 521-536

120

119

165

1466

13194 Levy YS, Stroomza M, Melamed E, Offen D

Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2004; 24 (3): 353-385

165

1467

16346 Boyd AS, Higashi Y, Wood KJ

Transplanting stem cells: Potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation

ADVANCED DRUG DELIVERY REVIEWS. 2005 DEC 12; 57 (13): 1944-1969

165

1468

16537 Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, et al.

Deep brain stimulation: Postoperative issues

MOVEMENT DISORDERS. 2006; 21: S219-S237

165

1469

17849 Croisier E, Graeber MB

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

ACTA NEUROPATHOLOGICA. 2006 NOV; 112 (5): 517-530

165

1470

17944 Burns A, O'Brien J

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology

JOURNAL OF PSYCHOPHARMACOLOGY. 2006 NOV; 20 (6): 732-755

165

Date / Author / Journal

LCS

GCS

LCR

1471

18199 de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, et al.

Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease

IMAGING AND THE AGING BRAIN. 2007; 1097: 114-145

165

1472

18944 Houben F, Ramaekers FCS, Snoeckx LHEH, Broers JLV

Role of nuclear lamina-cytoskeleton interactions in the maintenance of cellular strength

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2007 MAY; 1773 (5): 675-686

165

1473

20046 Uversky VN, Oldfield CJ, Dunker AK

Intrinsically disordered proteins in human diseases: Introducing the D- 2 concept

ANNUAL REVIEW OF BIOPHYSICS. 2008; 37: 215-246

165

1474

21730 Rebolledo DL, Minniti AN, Grez PM, Fadic R, Kohn R, et al.

Inclusion Body Myositis: A View from the Caenorhabditis elegans Muscle

MOLECULAR NEUROBIOLOGY. 2008 OCT; 38 (2): 178-196

165

1475

23905 Lucin KM, Wyss-Coray T

Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?

NEURON. 2009 OCT 15; 64 (1): 110-122

165

1476

24025 Farin A, Liu CY, Langmoen IA, Apuzzo MLJ

BIOLOGICAL RESTORATION OF CENTRAL NERVOUS SYSTEM ARCHITECTURE AND FUNCTION: PART 3-STEM CELL- AND CELL-BASED APPLICATIONS AND REALITIES IN THE BIOLOGICAL MANAGEMENT OF CENTRAL NERVOUS SYSTEM DISORDERS: TRAUMATIC, VASCULAR, AND EPILEPSY DISORDERS

NEUROSURGERY. 2009 NOV; 65 (5): 831-859

165

1477

25191 Chouliaras L, Rutten BPF, Kenis G, Peerbooms O, Visser PJ, et al.

Epigenetic regulation in the pathophysiology of Alzheimer's disease

PROGRESS IN NEUROBIOLOGY. 2010 APR; 90 (4): 498-510

165

1478

25387 Frade JM, Lopez-Sanchez N

A novel hypothesis for Alzheimer's disease based on neuronal tetraploidy induced by p75(NTR)

CELL CYCLE. 2010 MAY 15; 9 (10): 1934-1941

165

1479

25457 Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, et al.

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 334-346

165

1480

26073 Kadir A, Nordberg A

Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia

JOURNAL OF NUCLEAR MEDICINE. 2010 SEP 1; 51 (9): 1418-1430

165

Date / Author / Journal

1481

ORGANIZATION OF THALAMIC PROJECTIONS IN THE NUCLEUS ACCUMBENS AND THE CAUDATE-NUCLEUS IN CATS AND ITS RELATION WITH HIPPOCAMPAL AND OTHER SUBCORTICAL AFFERENTS

JOURNAL OF COMPARATIVE NEUROLOGY. 1985; 231 (3): 396-420

164

1482

886 SCHEITHAUER BW, BRUNER JM

THE ULTRASTRUCTURAL SPECTRUM OF ASTROCYTIC NEOPLASMS

ULTRASTRUCTURAL PATHOLOGY. 1987; 11 (5-6): 535-581

164

1483

1823 GREENBERG BD, KEZDY FJ, KISILEVSKY R

AMYLOIDOGENESIS AS A THERAPEUTIC TARGET IN ALZHEIMERS-DISEASE

ANNUAL REPORTS IN MEDICINAL CHEMISTRY. 1991; 26: 229-238

164

1484

3882 PANTONI L, GARCIA JH

THE SIGNIFICANCE OF CEREBRAL WHITE-MATTER ABNORMALITIES 100 YEARS AFTER BINSWANGERS REPORT - A REVIEW

STROKE. 1995 JUL; 26 (7): 1293-1301

314

164

1485

6504 Rogers MA, Bradshaw JL, Pantelis C, Phillips JG

Frontostriatal deficits in unipolar major depression

BRAIN RESEARCH BULLETIN. 1998 NOV 1; 47 (4): 297-310

164

1486

7884 Dryhurst G, Shen XM, Li H, Yang ZL, Han JL, et al.

Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease

NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS. 2000; : 181-209

164

1487

7895 Schallert T, Bland ST, Fleming SM

Functional recovery after brain injury: role of neurotrophic factors and behavior-driven structural events

PHARMACOLOGY OF CEREBRAL ISCHEMIA 2000. 2000; : 329-344

164

1488

9238 Bigler ED

The lesion(s) in traumatic brain injury: implications for clinical neuropsychology

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2001 FEB; 16 (2): 95-131

164

1489

9406 Lam PYP, Breakefield XO

Potential of gene therapy for brain tumors

HUMAN MOLECULAR GENETICS. 2001 APR; 10 (7): 777-787

164

1490

11274 Thompson AJ, Barrow CJ

Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and prion diseases

CURRENT MEDICINAL CHEMISTRY. 2002 OCT; 9 (19): 1751-1762

164

Date / Author / Journal

LCS

GCS

LCR

1491

12843 Ciechanover A, Brundin P

The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg

NEURON. 2003 OCT 9; 40 (2): 427-446

101

319

164

1492

13130 Brown DR, Kozlowski H

Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases

DALTON TRANSACTIONS. 2004; (13): 1907-1917

164

1493

13153 Ben-Shachar D, Laifenfeld D

Mitochondria, synaptic plasticity, and schizophrenia

DISORDERS OF SYNAPTIC PLASTICITY AND SCHIZOPHRENIA. 2004; 59: 273-296

164

1494

14614 Bulte JWM, Kraitchman DL

Monitoring cell therapy using iron oxide MR contrast agents

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2004 DEC; 5 (6): 567-584

164

1495

15516 Sun Y, MacRae TH

The small heat shock proteins and their role in human disease

FEBS JOURNAL. 2005 JUN; 272 (11): 2613-2627

129

164

1496

16383 Maruszak A, Gaweda-Walerych K, Soltyszewski I, Kekanowski C

Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases

ACTA NEUROBIOLOGIAE EXPERIMENTALIS. 2006; 66 (2): 153-176

164

1497

16782 Shults CW

Lewy bodies

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 FEB 7; 103 (6): 1661-1668

108

110

164

1498

16994 Bacman SR, Bradley WG, Moraes CT

Mitochondrial involvement in amyotrophic lateral sclerosis - Trigger or target?

MOLECULAR NEUROBIOLOGY. 2006 APR; 33 (2): 113-131

164

1499

17798 Hardy J

A hundred years of Alzheimer's disease research

NEURON. 2006 OCT 5; 52 (1): 3-13

164

1500

18567 D Roses A, Saunders AM, Huang Y, Strum J, Weisgraber KH, et al.

Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)

PHARMACOGENOMICS JOURNAL. 2007 FEB; 7 (1): 10-28

164

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records